Cytokinetics’ promising pipeline: a value stock for a long term investor.

Cytokinetics’ promising pipeline: a value stock for a long term investor.

(As originally published on Seeking Alpha on July 20, 2011). Also, check my latest update on Cytokinetics here.

Throughout this year, Cytokinetics’ shares have been moving between $1.12 and $2.96. During this time, the stock has been knocked down more than 60% and the recent turbulence in the market has not helped much either. This is a report on the main programs of the company plus some fundamental and technical analysis that will hopefully shed light on what a long term investor should expect from Cytokinetics.
[Read more...]